Serge Saxonov is the co-founder and CEO of 10x Genomics, a leader in single cell and spatial biology. 10x’s mission is to accelerate the mastery of biology to advance human health. Under Serge’s leadership, 10x has delivered groundbreaking products that have transformed how researchers explore biology. These tools and technologies have been cited in more than 10,000 high-impact publications and have enabled discoveries across nearly every area of life sciences.
As a scientist, inventor and entrepreneur, Serge guided 10x from an early-stage startup through one of the fastest revenue ramps in the industry’s history to its public debut on Nasdaq (TXG), and has since led the company’s continued growth and innovation. Before 10x, he was part of the founding team at 23andme, where he pioneered the company’s core technology and product concepts, and later served as Vice President of Applications at QuantaLife, which was acquired by Bio-Rad.
Serge’s leadership and entrepreneurship have been recognized by Goldman Sachs, which named him one of its “100 Most Intriguing Entrepreneurs” in 2016, and by the San Francisco Business Times, which honored him as one of the Bay Area’s “Most Admired CEOs” in 2021. He earned his A.B. in Applied Mathematics from Harvard College and his Ph.D. in Biomedical Informatics from Stanford University.
